Corporate News – Market Update
Cellectar Biosciences (CLRB)
- Price movement (last 24 h): up 9.82 %
- Closing price: USD 1.26 (05:41 PM Central Europe, Wednesday 21 Oct 2026)
- Shares outstanding: 9.5 million
- Market capitalization: USD 10.6 million
- Volume (last 24 h): USD 133.8 thousand
- Performance since last month‑end: down 47.66 %
- 200‑day simple moving average: USD 2.72
- 52‑week high: USD 4.70 (05 May 2026)
- 52‑week low: USD 1.12 (20 Oct 2026)
Recent Trading Activity of Related Stocks
| Symbol | Ticker | 24‑h change | Current price | Market cap |
|---|---|---|---|---|
| Veea | VEEA | –0.99 % | USD 3.96 | USD 12.6 million |
| Lipocine | LPCN | +5.88 % | USD 1.64 | USD 12.6 million |
| Air Industries | AIRI | 0 % | USD 2.48 | USD 12 million |
| Biofrontera | BFRI | –0.25 % | USD 0.80 | USD 12 million |
| Rocket One | RKTO | +6.84 % | USD 0.54 | USD 12.4 million |
Lipocine (LPCN) – On 20 Oct 2026, the company filed a Form 8‑K reporting no material adverse events, confirming its status as a Nasdaq‑listed issuer and unchanged corporate structure.
Air Industries (AIRI) – Third‑quarter results aligned with the previous year; revenue stable, telecom segment slight decline, software services growth. Strategic shift includes discontinuing the public switched telephone network and focusing on data‑center connectivity.
Rocket One (RKTO) – Announced a one‑year research partnership with Virginia Commonwealth University to develop straintronic magnetic tunnel junctions for ultra‑low‑power AI chips. The partnership provides licensing options for intellectual property and targets applications in defense and space.
Company Profile – Cellectar Biosciences
Cellectar Biosciences Inc. is a pharmaceutical company that develops drugs for the treatment and diagnosis of various cancers. The company’s operations are based in Middleton, United States, and it focuses on the healthcare sector, particularly biotechnology. Cellectar Biosciences trades on the Nasdaq stock exchange and provides its products to medical, pharmaceutical, and healthcare industries. More information is available on the company’s website: www.cellectar.com .
